TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

AI-Based Pathology Classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

Sebastian Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.